跳到正文
心血管健康队列研究4 分钟阅读

成年早期起血压偏高且持续上升,与晚年更多脑损伤相关

MoveVitals 编辑部 · 研究发表 · 解读更新

原文:Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. · The Lancet. Neurology · 2019 · 论文原文 ↗

先看重点

在1946年英国出生队列中465名无痴呆者里,53岁时收缩压每高10 mm Hg,69-71岁MRI上的脑白质高信号体积(WMHV)平均大7%(95%置信区间1-14)。血压与β淀粉样蛋白状态和认知评分无关,且这是只涉及一个出生年份的观察性队列。

证据类型

队列研究

解读依据

公开摘要

阅读重点

关联与混杂

研究在问什么

中年高血压会增加日后认知障碍的风险,但风险暴露的敏感时期,以及损害是通过淀粉样蛋白还是血管机制介导,目前了解不多。作者想弄清成年期的血压或其变化是否、以及在何时与晚年的脑结构、病理和认知相关。

研究了谁,如何研究

分析来自Insight 46,这是医学研究理事会全国健康与发育调查的神经科学子研究,该出生队列最初有5362人,均于1946年同一周在英国出生。69-71岁的参与者均无痴呆,接受容积MRI、氟贝他吡PET淀粉样蛋白成像和认知测试(临床前阿尔茨海默认知综合评分,PACC)。血压分别在36、43、53、60-64和69岁测量,并计算各年龄之间的变化。结局包括WMHV、β淀粉样蛋白阳性、全脑和海马体积以及PACC,使用广义线性、logistic和线性回归并校正潜在混杂因素。2015年5月28日至2018年1月10日共评估502人,465人纳入影像分析(男性238人[51%];平均年龄70.7岁;β淀粉样蛋白阳性83人[18%])。

主要发现

以下为作者报告的结果。数字须连同人群和不确定性一起阅读。

  1. 1
    53岁时血压较高、43至53岁之间血压升幅较大,与69-71岁MRI上更多的脑白质损伤相关:收缩压每高10 mm Hg,平均WMHV高7%(95%置信区间1-14,p = 0.024);舒张压每高10 mm Hg,高15%(95%置信区间4-27,p = 0.0057)。
  2. 2
    每变化1个标准差,收缩压对应的WMHV高15%(95%置信区间3-29,p = 0.012),舒张压对应的WMHV高15%(95%置信区间3-30,p = 0.017)。
  3. 3
    43岁时舒张压较高与69-71岁全脑体积较小相关(每高10 mm Hg为-6.9 mL,95%置信区间-11.9至-1.9,p = 0.0068),36至43岁之间舒张压升幅较大也是如此(每1个标准差-6.5 mL,95%置信区间-11.1至-1.9,p = 0.0054)。
  4. 4
    36至43岁之间收缩压升幅较大,与海马体积较小相关(每1个标准差-0.03 mL,95%置信区间-0.06至-0.001,p = 0.043)。
  5. 5
    绝对血压及其变化均不能预测β淀粉样蛋白状态或PACC评分。

局限与不确定性

  1. 1
    仅分析了465人,均来自同一年龄的英国出生队列且无痴呆,结果未必适用于其他人群或世代。
  2. 2
    研究在多个年龄和多个结局之间做了许多比较,部分效应接近临界(如p = 0.043),海马体积的差异非常小。
  3. 3
    作者未发现血压在该年龄影响认知或淀粉样蛋白的证据,因此这里并未证明血压与痴呆风险本身相关。
  4. 4
    作为观察性研究,它不能证明在40岁左右降压就能保护大脑;本解读仅基于摘要。

对日常健康的启示

这项研究支持从中年甚至更早就把血压控制好,因为血压偏高且持续上升与几十年后更多的小血管损伤和较小的脑体积相关。但它并未证明40岁开始治疗就能预防这些变化。血压目标和治疗决定应由医生做出。

如何联系自己的数据

家用上臂血压计是最直接相关的设备。请在每天同一时间、坐姿放松后、使用同一台血压计测量,看多次读数的平均值以及数月乃至数年的变化,而不要只看一次读数;并把记录带给医生。

如何理解这类证据

暴露先于随访结局,仍可能存在混杂和反向因果。危险比不是个人绝对风险,也不等于已证明的干预效果。

作者的结构化摘要 English

以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。

Background

Midlife hypertension confers increased risk for cognitive impairment in late life. The sensitive period for risk exposure and extent that risk is mediated through amyloid or vascular-related mechanisms are poorly understood. We aimed to identify if, and when, blood pressure or change in blood pressure during adulthood were associated with late-life brain structure, pathology, and cognition.

Methods

Participants were from Insight 46, a neuroscience substudy of the ongoing longitudinal Medical Research Council National Survey of Health and Development, a birth cohort that initially comprised 5362 individuals born throughout mainland Britain in one week in 1946. Participants aged 69-71 years received T1 and FLAIR volumetric MRI, florbetapir amyloid-PET imaging, and cognitive assessment at University College London (London, UK); all participants were dementia-free. Blood pressure measurements had been collected at ages 36, 43, 53, 60-64, and 69 years. We also calculated blood pressure change variables between ages. Primary outcome measures were white matter hyperintensity volume (WMHV) quantified from multimodal MRI using an automated method, amyloid-β positivity or negativity using a standardised uptake value ratio approach, whole-brain and hippocampal volumes quantified from 3D-T1 MRI, and a composite cognitive score-the Preclinical Alzheimer Cognitive Composite (PACC). We investigated associations between blood pressure and blood pressure changes at and between 36, 43, 53, 60-64, and 69 years of age with WMHV using generalised linear models with a gamma distribution and log link function, amyloid-β status using logistic regression, whole-brain volume and hippocampal volumes using linear regression, and PACC score using linear regression, with adjustment for potential confounders.

Findings

Between May 28, 2015, and Jan 10, 2018, 502 individuals were assessed as part of Insight 46. 465 participants (238 [51%] men; mean age 70·7 years [SD 0·7]; 83 [18%] amyloid-β-positive) were included in imaging analyses. Higher systolic blood pressure (SBP) and diastolic blood pressure (DBP) at age 53 years and greater increases in SBP and DBP between 43 and 53 years were positively associated with WMHV at 69-71 years of age (increase in mean WMHV per 10 mm Hg greater SBP 7%, 95% CI 1-14, p=0·024; increase in mean WMHV per 10 mm Hg greater DBP 15%, 4-27, p=0·0057; increase in mean WMHV per one SD change in SBP 15%, 3-29, p=0·012; increase in mean WMHV per 1 SD change in DBP 15%, 3-30, p=0·017). Higher DBP at 43 years of age was associated with smaller whole-brain volume at 69-71 years of age (-6·9 mL per 10 mm Hg greater DBP, -11·9 to -1·9, p=0·0068), as were greater increases in DBP between 36 and 43 years of age (-6·5 mL per 1 SD change, -11·1 to -1·9, p=0·0054). Greater increases in SBP between 36 and 43 years of age were associated with smaller hippocampal volumes at 69-71 years of age (-0·03 mL per 1 SD change, -0·06 to -0·001, p=0·043). Neither absolute blood pressure nor change in blood pressure predicted amyloid-β status or PACC score at 69-71 years of age.

Interpretation

High and increasing blood pressure from early adulthood into midlife seems to be associated with increased WMHV and smaller brain volumes at 69-71 years of age. We found no evidence that blood pressure affected cognition or cerebral amyloid-β load at this age. Blood pressure monitoring and interventions might need to start around 40 years of age to maximise late-life brain health.

Funding

Alzheimer's Research UK, Medical Research Council, Dementias Platform UK, Wellcome Trust, Brain Research UK, Wolfson Foundation, Weston Brain Institute, Avid Radiopharmaceuticals.

来源与署名

Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.

Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, Malone IB, Lu K, James SN, Keshavan A, Murray-Smith H, Wong A, Buchanan SM, Keuss SE, Gordon E, Coath W, Barnes A, Dickson J, Modat M, Thomas D, Crutch SJ, Hardy R, Richards M, Fox NC, Schott JM.

The Lancet. Neurology · 2019-08-20

DOI: 10.1016/s1474-4422(19)30228-5 ↗PubMed · 31444142 ↗Europe PMC · 记录的开放许可: cc by ↗

摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。

MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅

来源核验日期 2026-11-01

实用健康指南

放在一起读

·观察研究荟萃分析

昼夜活动节律紊乱与更高的死亡风险相关(109,365人)

在7项观察性研究、共109,365名参与者中,昼夜活动对比较弱(相对振幅较低)与更高的心血管死亡风险(风险比[HR]1.50,95%置信区间1.13至1.98)和全因死亡风险(HR 1.46,95%置信区间1.27至1.68)相关。证据基础小,又是观察性的,不能说明改善节律就能降低风险,疾病本身也可能扰乱节律。

Journal of the American Heart Association

重点论文精讲阅读论文 →
·随机试验荟萃分析

五类运动都降低了静息血压,等长训练降幅最大

汇总270项随机试验、共15,827名参与者的结果,有氧、抗阻、联合、间歇和等长训练与无干预对照组相比都降低了静息血压(各P<0.001),其中等长训练降幅最大:收缩压下降8.24 mm Hg,舒张压下降4.00 mm Hg。各方式之间的排序部分来自间接比较,各试验也不尽相同,所以排序不是个人的运动处方。

British Journal of Sports Medicine

重点论文精讲阅读论文 →
·随机对照试验

盐替代品使中国农村高危人群的卒中、主要心血管事件和死亡率下降

在中国农村600个村庄、20,995名有卒中史或年龄在60岁及以上且有高血压的人中,使用盐替代品(氯化钠75%、氯化钾25%)的卒中发生率低于普通盐:平均随访4.74年,每1000人年29.14次对33.65次(率比0.86,95%置信区间0.77至0.96;P=0.006)。死亡也更低(率比0.88),严重高钾血症事件没有显著增多,但试验为开放标签设计,且在中国农村开展。

The New England Journal of Medicine

重点论文精讲阅读论文 →
·测量验证研究/综述

智能手表脉搏不规则提醒较少见,做贴片检查者34%确有房颤

在419,297名没有已知心房颤动(房颤)的苹果手表用户中,0.52%收到脉搏不规则提醒;返还可用心电贴片的450人中,34%确认有房颤(97.5%置信区间29至39)。提醒发出时恰有贴片记录的,通知的阳性预测值为0.84(95%置信区间0.76至0.92),但收到提醒者中仅20.8%返还了贴片,没有收到提醒的人未被监测,所以手表没有提醒并不能排除房颤。

The New England Journal of Medicine

重点论文精讲阅读论文 →
心血管健康 →